Pressure Biosciences (PBIO.OB) Technologies Help Identify Biomarkers for Breast and Colon Cancers
Recently Dr. Paul Pevsner of the New York University of Medicine presented four posters at a LC –MS course held at Cambridge University England. During his presentation Dr. Pevsner stated that the company’s newest innovative product (ProteoSolve LRS) was instrumental in the discovery of certain Bio-Markers in Breast and Colon cancer that could signal the disease. This patented technology allows for detergent free extraction of the lipids giving a much more homogeneous sample. Dr. Pevsner stated the following regarding Pressure Biseciences products, “The combination of PCT and ProteoSolveLRS is particularly suited for the study of the small, often nano-quantities of…